Penn Scientists Match 'Molecular Gates' in Mammals and Primitive Bacterial Animals

Research on components of the brain's electrical signaling system has answered a basic question about our human evolution, confirming scientific belief that we two-legged, computer-using creatures are descended from prokaryotes -- cellular organisms so primitive and simple that they exist without nuclei or cell walls.

The study, led by Zhe Lu, MD, PhD, an Associate Professor in the Department of Physiology at the University of Pennsylvania School of Medicine have been recently published in the journal Nature.

The research by Lu and his colleagues focused on the structure and function of molecules called potassium channels, which are essential to how the brain works. When potassium channels open and close, they control the flow of potassium ions across cell membranes. The current contributes to the electrical signals in nerve, muscle and endocrine cells.

Scientists who study the brain's electrical signals have relied on a blue-print developed from functional studies of eukaryotic (neuronal) potassium channels and structural studies of prokaryotic (bacterial) potassium channels, based on the assumption that the two channels are essentially the same. However this assumption has recently been challenged.

Lu and his collaborators devised a project in which the pore of a prokaryote's potassium channel (the interior core of the channel) was substituted for the pore of a potassium channel in a euokaryote. The scientists found that the eukarotic channel continued to function essentially as it had previous to the substitution.

"This has very profound implications for evolution," Lu said. "It appears the potassium channels in advanced brains and hearts of mammals have evolved from something like this bacterial channel. So what we learn from the more easily studied bacterial channels can be directly applied to our understanding of potassium channels such as those in our brains."

In the study, Lu worked with Penn colleagues, Angela Klem, research specialist, and Yajamana Ramu, PhD.

The work was funded by the National Institutes of Health.


//////////////////////


The University of Pennsylvania Health System is distinguished not only by its historical significance -- first hospital (1751), first medical school (1765), first university teaching hospital (1874), first fully integrated academic health system (1993) -- but by its leadership in the practice of medicine in the 21st Century. Among all American medical schools, Penn ranks second in funding from the National Institutes of Health, perhaps the single most important barometer of research strength.

 

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.

The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.

The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.

Share This Page: